Jeffrey M. Besterman
Corporate Officer/Principal at National Cancer Institute
Jeffrey M. Besterman active positions
| Companies | Position | Start | End |
|---|---|---|---|
National Cancer Institute
 National Cancer Institute Investment Trusts/Mutual FundsMiscellaneous National Cancer Institute provides healthcare services. It specializes in different cancer treatment such as adrenocortical carcinoma, anal cancer, appendix cancer, skin cancer, breast cancer, cardiac tumors, endometrial cancer, and gallbladder cancer. The company was founded in March 1937 and is headquartered in Bethesda, MD. | Corporate Officer/Principal | - | - |
Career history of Jeffrey M. Besterman
Former positions of Jeffrey M. Besterman
| Companies | Position | Start | End |
|---|---|---|---|
| MIRATI THERAPEUTICS | Chief Tech/Sci/R&D Officer | 31/12/1996 | 13/03/2013 |
GlaxoSmithKline Research & Development
 GlaxoSmithKline Research & Development Pharmaceuticals: MajorHealth Technology GlaxoSmithKline Research & Development manufactures pharmaceutical products. It has locations in the U.S. and across Europe. The company has treatments in the works for therapies such as infectious diseases, neuroscientific requirements and respiratory needs. GlaxoSmithKline is located in Research Triangle Park, NC | Corporate Officer/Principal | - | - |
Training of Jeffrey M. Besterman
| The State University of New York | Undergraduate Degree |
| University of Vermont | Doctorate Degree |
Statistics
International
| United States | 6 |
Operational
| Corporate Officer/Principal | 2 |
| Chief Tech/Sci/R&D Officer | 1 |
| Undergraduate Degree | 1 |
Sectoral
| Health Technology | 3 |
| Consumer Services | 3 |
| Miscellaneous | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Private companies | 3 |
|---|---|
Mirati Therapeutics, Inc.
 Mirati Therapeutics, Inc. BiotechnologyHealth Technology Mirati Therapeutics, Inc. operates as a clinical-stage oncology company. engages in the development of novel therapeutics. The firm's products target the genetic and immunological promoters of cancer. Its clinical pipeline consists of Adagrasib, MRTX1133, and Sitravatinib. The company was founded on December 13, 1995, and is headquartered in San Diego, CA. | Health Technology |
National Cancer Institute
National Cancer Institute Investment Trusts/Mutual FundsMiscellaneous National Cancer Institute provides healthcare services. It specializes in different cancer treatment such as adrenocortical carcinoma, anal cancer, appendix cancer, skin cancer, breast cancer, cardiac tumors, endometrial cancer, and gallbladder cancer. The company was founded in March 1937 and is headquartered in Bethesda, MD. | Miscellaneous |
GlaxoSmithKline Research & Development
GlaxoSmithKline Research & Development Pharmaceuticals: MajorHealth Technology GlaxoSmithKline Research & Development manufactures pharmaceutical products. It has locations in the U.S. and across Europe. The company has treatments in the works for therapies such as infectious diseases, neuroscientific requirements and respiratory needs. GlaxoSmithKline is located in Research Triangle Park, NC | Health Technology |
- Stock Market
- Insiders
- Jeffrey M. Besterman
- Experience
